US Approves Weight-loss Drug to Reduce Heart Disease Risk — VOA Learning English
Topics: подорожі й побут
Beginning
From VOA Learning English, this is the Health & Lifestyle report.
In 2021, the U.S. food and drug agency approved the drug Wegovy for weight loss. Now, the Food and Drug Administration (or, FDA) says the drug can reduce the risk of death from stroke or heart attack in adults who have cardiovascular disease or are overweight.
The FDA approved a usage change requested by drugmaker Novo Nordisk. The change expands the use of semaglutide, the general or generic name of the drug. Wegovy is the brand name given by the company that sells it.
The FDA based its decision on the results of a study that found Wegovy cut the risk of serious heart problems. The study also found that overweight patients with…
Tap any word for its translation at once; the word goes into your deck together with its sentence.